CRDF Financials
Cardiff Oncology Inc - Financial statements & key metrics
Stock Price
$1.03
Market Cap
$238.83M
P/E Ratio
-1.1
EPS
$-0.79
Income Statement Highlights
Most Recent Quarter: 2024-12-31
Revenue
$683,000
Gross Profit
-
Operating Income
-
Net Income
$-45.43M
EPS (Diluted)
$-0.95
Balance Sheet Highlights
Total Assets
$97.19M
Total Liabilities
$14.24M
Shareholders Equity
-
Cash & Equivalents
$51.47M
Total Debt
-
Cash Flow Highlights
Operating Cash Flow
$-37.69M
CapEx
-
Free Cash Flow
-
Profitability Metrics
Operating Margin
-9978.3%
ROE
-102.7%
View Complete Financial Statements
Full income statements, balance sheets, and cash flows for multiple periods
Open Full FinancialsFrequently Asked Questions
What is CRDF revenue?
CRDF's most recent quarterly revenue was $683,000. Annual revenue can be calculated by summing the four most recent quarters.
Is CRDF profitable?
CRDF reported a loss of $45.43M in the most recent quarter.
What is CRDF market cap?
CRDF has a market capitalization of $238.83M, making it a small-cap stock.
Does CRDF have debt?
View CRDF's balance sheet for debt information.
What is CRDF cash flow?
Cash flow data is available in the full financial statements.